Eli Lilly Projects $82B-$85B Revenue and $35.50-$37 EPS for 2026 Amid Foundayo Launch

Eli Lilly has projected its 2026 revenue to be between $82 billion and $85 billion, with non-GAAP earnings per share estimated at $35.50 to $37. These projections come as the company begins the launch of its new product, Foundayo.